| 臺大學術典藏 |
2022-03-04T03:48:44Z |
Prediction of heat-induced Collagen shrinkage by use of second harmonic generation microscopy
|
Lin S.-J.; Lo W.; Tan H.-Y.; Chan J.-Y.; Chen W.-L.; Wang S.-H.; Sun Y.; WEI-CHOU LIN; Chen J.-S.; Hsu C.-J.; Tjiu J.-W.; Yu H.-S.; Jee S.-H.; Dong C.-Y. |
| 臺大學術典藏 |
2022-03-04T03:48:42Z |
Multiphoton fluorescence and second harmonic generation imaging of the structural alterations in keratoconus ex vivo
|
Tan H.-Y.; Sun Y.; Lo W.; Lin S.-J.; Hsiao C.-H.; Chen Y.-F.; Huang S.C.-M.; WEI-CHOU LIN; Jee S.-H.; Yu H.-S.; Dong C.-Y. |
| 臺大學術典藏 |
2022-02-10T06:48:32Z |
Anti-CD45 antibody enhances lipoxygenase pathway of human naïve mononuclear cells and cyclooxygenase pathway of neutrophils
|
Wu, C-H; Hsieh, S-C; Yu, H-S; KO-JEN LI; Lu, M-C; Tsai, C-Y; Yu, C-L |
| 臺大學術典藏 |
2022-02-10T06:28:29Z |
Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils
|
Hsieh, S C; Yu, H S; Cheng, S H; KO-JEN LI; Lu, M C; Wu, C H; Tsai, C Y; Yu, C L |
| 臺大學術典藏 |
2021-11-18T04:58:19Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L; Hsu C.-H; Lin J.-K; Hsu M.-M; Ho Y.-F; She T.-S; JENG-YUH KO; Lin J.-T; Lin B.-R; Wu M.-S; Yu H.-S; Jee S.-H; Chen G.-S; Chen T.-M; Chen C.-A; Lai M.-K; Pu Y.-S; Pan M.-H; Wang Y.-J; Tsai C.-C; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-11-15T07:48:43Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L; Hsu C.-H; Lin J.-K; Hsu M.-M; Ho Y.-F; She T.-S; JENG-YUH KO; Lin J.-T; Lin B.-R; Wu M.-S; Yu H.-S; Jee S.-H; Chen G.-S; Chen T.-M; Chen C.-A; Lai M.-K; Pu Y.-S; Pan M.-H; Wang Y.-J; Tsai C.-C; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-11-08T08:01:08Z |
Assessment of burden of illness due to herpes zoster and predictors of outcomes in Taiwan: a prospective observational study
|
TSEN-FANG TSAI; Yu, H.-S.; Rampakakis, E.; Duong, A.; White, R.R.; Acosta, C.; Sampalis, J.S. |
| 臺大學術典藏 |
2021-02-02T08:29:56Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; BOR-RU LIN; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:22:37Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; MING-SHIANG WU; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:47:06Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.;Hsu C.-H.;Lin J.-K.;Hsu M.-M.;Ho Y.-F.;She T.-S.;Ko J.-Y.;Lin J.-T.;Lin B.-R.;Wu M.-S.;Yu H.-S.;Jee S.-H.;Chen G.-S.;Chen T.-M.;Chen C.-A.;Lai M.-K.;Yeong-Shiau Pu;Pan M.-H.;Wang Y.-J.;Tsai C.-C.;Hsieh C.-Y.; Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; YEONG-SHIAU PU; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
